TMCnet5h
Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)
The Company granted options to purchase 611,000 shares of Terns common stock to the new employees. The options have a 10-year term and an exercise price per share equal to $2.56, which was the closing ...
TMCnet4h
Office Properties Income Trust First Quarter 2025 Conference Call Scheduled for Thursday, May 1st
Office Properties Income Trust (Nasdaq: OPI) today announced that it will issue a press release containing its first quarter 2025 financial results after the Nasdaq closes on Wednesday, April 30, 2025 ...
TMCnet3h
Mid Penn Bancorp, Inc. and William Penn Bancorporation Receive Shareholder Approvals for Merger
Mid Penn Bancorp, Inc. ("Mid Penn") (NASDAQ: MPB) and William Penn Bancorporation ("William Penn") (NASDAQ: WMPN) announced today that shareholders from both Mid Penn and William Penn overwhelmingly ...
TMCnet5h
Commvault Announces Fourth Quarter Fiscal 2025 Earnings Release Date
TINTON FALLS, N.J., April 2, 2025 /PRNewswire/ -- Commvault (NASDAQ: CVLT) - Commvault will webcast a discussion of its fourth quarter fiscal year 2025 earnings results on Tuesday, April 29, 2025 ...
TMCnet4h
Astronics Announces the Innovative SkyShow Server: A New Standard in In-Cabin Moving Map Technology
Developed with FlightPath3D's premier software, the SkyShow Server is an ideal solution for airlines seeking to modernize ...
TMCnet2h
Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure
Mesoblast filed a request for a Type B meeting during the last quarter, in line with previous guidance, and expects to have the meeting during this quarter. The meeting will be held under Mesoblast’s ...
TMCnet2h
Securities Fraud Investigation Into TechTarget, Inc. (TTGT) Announced - Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of TechTarget, Inc. ("TechTarget" or the "Company") (NASDAQ: TTGT) on behalf of investors concerning the Company's possible violations of ...
TMCnet5h
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
“This investigational strategy allows us to collect product performance data on Re-Tain® while full NADA approval is pending the final stages of review,” commented Michael F. Brigham, President and ...
TMCnet5h
FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place ...
TMCnet4h
Autodesk announces Betsy Rafael to step down from Board of Directors
"On behalf of the full Board, I would like to express my sincere gratitude for Betsy's outstanding contributions and commitment to Autodesk over more than a decade,"said Andrew Anagnost, Autodesk ...
TMCnet5h
Lam Research Corporation Announces March Quarter Financial Conference Call
FREMONT, Calif., April 2, 2025 /PRNewswire/ -- Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, April 23, ...
TMCnet4h
VTRS Investors Have Opportunity to Join Viatris Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for ...